nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—ADRA2A—type 2 diabetes mellitus	0.145	0.325	CbGaD
Bromocriptine—HTR2C—type 2 diabetes mellitus	0.133	0.299	CbGaD
Bromocriptine—CYP1A2—type 2 diabetes mellitus	0.101	0.226	CbGaD
Bromocriptine—CYP3A4—type 2 diabetes mellitus	0.0666	0.15	CbGaD
Bromocriptine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0276	0.119	CbGbCtD
Bromocriptine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0246	0.106	CbGbCtD
Bromocriptine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0188	0.081	CbGbCtD
Bromocriptine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0178	0.0768	CbGbCtD
Bromocriptine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0166	0.0714	CbGbCtD
Bromocriptine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0148	0.0638	CbGbCtD
Bromocriptine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0148	0.0636	CbGbCtD
Bromocriptine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0135	0.0582	CbGbCtD
Bromocriptine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0118	0.0509	CbGbCtD
Bromocriptine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0107	0.046	CbGbCtD
Bromocriptine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00953	0.0411	CbGbCtD
Bromocriptine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00911	0.0393	CbGbCtD
Bromocriptine—ABCB1—Losartan—type 2 diabetes mellitus	0.00834	0.0359	CbGbCtD
Bromocriptine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00808	0.0349	CbGbCtD
Bromocriptine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00775	0.0334	CbGbCtD
Bromocriptine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00775	0.0334	CbGbCtD
Bromocriptine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00546	0.0235	CbGbCtD
Bromocriptine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00499	0.0215	CbGbCtD
Bromocriptine—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00274	0.0746	CbGeAlD
Bromocriptine—HTR2A—arteriole—type 2 diabetes mellitus	0.00269	0.073	CbGeAlD
Bromocriptine—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.00184	0.0502	CbGeAlD
Bromocriptine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00171	0.0465	CbGeAlD
Bromocriptine—DRD1—nerve—type 2 diabetes mellitus	0.00166	0.0451	CbGeAlD
Bromocriptine—HTR1B—artery—type 2 diabetes mellitus	0.00136	0.0369	CbGeAlD
Bromocriptine—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.00133	0.0362	CbGeAlD
Bromocriptine—HTR1D—artery—type 2 diabetes mellitus	0.00131	0.0357	CbGeAlD
Bromocriptine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.00115	0.0313	CbGeAlD
Bromocriptine—HTR2A—hindlimb—type 2 diabetes mellitus	0.00106	0.0289	CbGeAlD
Bromocriptine—HTR7—artery—type 2 diabetes mellitus	0.00105	0.0284	CbGeAlD
Bromocriptine—HTR7—nerve—type 2 diabetes mellitus	0.00104	0.0282	CbGeAlD
Bromocriptine—DRD2—nerve—type 2 diabetes mellitus	0.000981	0.0267	CbGeAlD
Bromocriptine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000976	0.0265	CbGeAlD
Bromocriptine—HTR7—endothelium—type 2 diabetes mellitus	0.000883	0.024	CbGeAlD
Bromocriptine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.00083	0.0226	CbGeAlD
Bromocriptine—HTR2A—artery—type 2 diabetes mellitus	0.000652	0.0177	CbGeAlD
Bromocriptine—HTR2A—nerve—type 2 diabetes mellitus	0.000647	0.0176	CbGeAlD
Bromocriptine—ADRA1B—kidney—type 2 diabetes mellitus	0.000611	0.0166	CbGeAlD
Bromocriptine—Dihydroergotamine—ADRA2A—type 2 diabetes mellitus	0.000605	0.151	CrCbGaD
Bromocriptine—HTR2A—endothelium—type 2 diabetes mellitus	0.000551	0.015	CbGeAlD
Bromocriptine—Ergonovine—HTR2C—type 2 diabetes mellitus	0.000509	0.127	CrCbGaD
Bromocriptine—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.000471	0.0128	CbGeAlD
Bromocriptine—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.000456	0.0124	CbGeAlD
Bromocriptine—HTR1D—kidney—type 2 diabetes mellitus	0.000446	0.0121	CbGeAlD
Bromocriptine—Methylergometrine—HTR2C—type 2 diabetes mellitus	0.000445	0.111	CrCbGaD
Bromocriptine—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.000443	0.0121	CbGeAlD
Bromocriptine—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.000424	0.0115	CbGeAlD
Bromocriptine—DRD2—retina—type 2 diabetes mellitus	0.000406	0.011	CbGeAlD
Bromocriptine—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.000404	0.011	CbGeAlD
Bromocriptine—ADRB1—adipose tissue—type 2 diabetes mellitus	0.000391	0.0106	CbGeAlD
Bromocriptine—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.00038	0.0103	CbGeAlD
Bromocriptine—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000374	0.0102	CbGeAlD
Bromocriptine—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000372	0.0101	CbGeAlD
Bromocriptine—Methysergide—HTR2C—type 2 diabetes mellitus	0.000372	0.0926	CrCbGaD
Bromocriptine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000369	0.01	CbGeAlD
Bromocriptine—Ergoloid mesylate—CYP3A4—type 2 diabetes mellitus	0.000367	0.0915	CrCbGaD
Bromocriptine—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000363	0.00988	CbGeAlD
Bromocriptine—HTR7—kidney—type 2 diabetes mellitus	0.000356	0.00967	CbGeAlD
Bromocriptine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000351	0.00953	CbGeAlD
Bromocriptine—ADRA2C—kidney—type 2 diabetes mellitus	0.000327	0.00889	CbGeAlD
Bromocriptine—ADRA2C—pancreas—type 2 diabetes mellitus	0.000325	0.00883	CbGeAlD
Bromocriptine—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.000318	0.00866	CbGeAlD
Bromocriptine—Ergotamine—ADRA2A—type 2 diabetes mellitus	0.000312	0.0777	CrCbGaD
Bromocriptine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000309	0.00841	CbGeAlD
Bromocriptine—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000295	0.00801	CbGeAlD
Bromocriptine—Ergotamine—HTR2C—type 2 diabetes mellitus	0.000287	0.0715	CrCbGaD
Bromocriptine—Dihydroergotamine—CYP3A4—type 2 diabetes mellitus	0.000278	0.0693	CrCbGaD
Bromocriptine—HTR2A—retina—type 2 diabetes mellitus	0.000268	0.00729	CbGeAlD
Bromocriptine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000259	0.00705	CbGeAlD
Bromocriptine—Ergonovine—CYP3A4—type 2 diabetes mellitus	0.000254	0.0634	CrCbGaD
Bromocriptine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000254	0.00691	CbGeAlD
Bromocriptine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000235	0.00639	CbGeAlD
Bromocriptine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000227	0.00616	CbGeAlD
Bromocriptine—HTR7—liver—type 2 diabetes mellitus	0.000225	0.00611	CbGeAlD
Bromocriptine—Methylergometrine—CYP3A4—type 2 diabetes mellitus	0.000222	0.0554	CrCbGaD
Bromocriptine—HTR2A—kidney—type 2 diabetes mellitus	0.000222	0.00603	CbGeAlD
Bromocriptine—ADRA1A—liver—type 2 diabetes mellitus	0.000217	0.0059	CbGeAlD
Bromocriptine—Ergotamine—CYP1A2—type 2 diabetes mellitus	0.000217	0.054	CrCbGaD
Bromocriptine—ADRA2C—liver—type 2 diabetes mellitus	0.000207	0.00562	CbGeAlD
Bromocriptine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000205	0.00558	CbGeAlD
Bromocriptine—CYP3A4—kidney—type 2 diabetes mellitus	0.000205	0.00558	CbGeAlD
Bromocriptine—CYP1A2—liver—type 2 diabetes mellitus	0.000179	0.00487	CbGeAlD
Bromocriptine—ABCB1—retina—type 2 diabetes mellitus	0.000176	0.00477	CbGeAlD
Bromocriptine—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000165	0.0045	CbGeAlD
Bromocriptine—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000149	0.00404	CbGeAlD
Bromocriptine—ABCB1—kidney—type 2 diabetes mellitus	0.000145	0.00395	CbGeAlD
Bromocriptine—ABCB1—pancreas—type 2 diabetes mellitus	0.000144	0.00393	CbGeAlD
Bromocriptine—Ergotamine—CYP3A4—type 2 diabetes mellitus	0.000143	0.0357	CrCbGaD
Bromocriptine—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000142	0.00385	CbGeAlD
Bromocriptine—HTR2A—liver—type 2 diabetes mellitus	0.00014	0.00381	CbGeAlD
Bromocriptine—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000131	0.00356	CbGeAlD
Bromocriptine—CYP3A4—liver—type 2 diabetes mellitus	0.00013	0.00353	CbGeAlD
Bromocriptine—Oedema—Orlistat—type 2 diabetes mellitus	0.000127	0.000819	CcSEcCtD
Bromocriptine—Headache—Glipizide—type 2 diabetes mellitus	0.000127	0.000818	CcSEcCtD
Bromocriptine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000127	0.000816	CcSEcCtD
Bromocriptine—Shock—Valsartan—type 2 diabetes mellitus	0.000127	0.000815	CcSEcCtD
Bromocriptine—Infection—Orlistat—type 2 diabetes mellitus	0.000126	0.000814	CcSEcCtD
Bromocriptine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000126	0.000813	CcSEcCtD
Bromocriptine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000126	0.000813	CcSEcCtD
Bromocriptine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000126	0.00081	CcSEcCtD
Bromocriptine—Tension—Losartan—type 2 diabetes mellitus	0.000125	0.000806	CcSEcCtD
Bromocriptine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000125	0.000806	CcSEcCtD
Bromocriptine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000125	0.000805	CcSEcCtD
Bromocriptine—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000125	0.000804	CcSEcCtD
Bromocriptine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000125	0.000804	CcSEcCtD
Bromocriptine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000125	0.000803	CcSEcCtD
Bromocriptine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000125	0.000803	CcSEcCtD
Bromocriptine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000125	0.000802	CcSEcCtD
Bromocriptine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000125	0.000802	CcSEcCtD
Bromocriptine—Hypertension—Metformin—type 2 diabetes mellitus	0.000124	0.000798	CcSEcCtD
Bromocriptine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000124	0.000798	CcSEcCtD
Bromocriptine—Nervousness—Losartan—type 2 diabetes mellitus	0.000124	0.000798	CcSEcCtD
Bromocriptine—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000124	0.000797	CcSEcCtD
Bromocriptine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000124	0.000796	CcSEcCtD
Bromocriptine—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000124	0.000795	CcSEcCtD
Bromocriptine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000123	0.000794	CcSEcCtD
Bromocriptine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000123	0.000794	CcSEcCtD
Bromocriptine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000123	0.00079	CcSEcCtD
Bromocriptine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000123	0.00079	CcSEcCtD
Bromocriptine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000122	0.000784	CcSEcCtD
Bromocriptine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000122	0.000783	CcSEcCtD
Bromocriptine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000122	0.000783	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000122	0.000782	CcSEcCtD
Bromocriptine—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000121	0.00078	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000121	0.000779	CcSEcCtD
Bromocriptine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000121	0.000778	CcSEcCtD
Bromocriptine—Nausea—Glipizide—type 2 diabetes mellitus	0.000121	0.000775	CcSEcCtD
Bromocriptine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00012	0.000775	CcSEcCtD
Bromocriptine—Hypotension—Valsartan—type 2 diabetes mellitus	0.00012	0.000774	CcSEcCtD
Bromocriptine—Vision blurred—Losartan—type 2 diabetes mellitus	0.00012	0.000774	CcSEcCtD
Bromocriptine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00012	0.000772	CcSEcCtD
Bromocriptine—Constipation—Gliclazide—type 2 diabetes mellitus	0.00012	0.000771	CcSEcCtD
Bromocriptine—Rash—Glimepiride—type 2 diabetes mellitus	0.000119	0.000768	CcSEcCtD
Bromocriptine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000119	0.000767	CcSEcCtD
Bromocriptine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000119	0.000767	CcSEcCtD
Bromocriptine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000119	0.000766	CcSEcCtD
Bromocriptine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000119	0.000765	CcSEcCtD
Bromocriptine—Headache—Glimepiride—type 2 diabetes mellitus	0.000119	0.000763	CcSEcCtD
Bromocriptine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000118	0.000761	CcSEcCtD
Bromocriptine—Agitation—Losartan—type 2 diabetes mellitus	0.000117	0.000755	CcSEcCtD
Bromocriptine—Oedema—Metformin—type 2 diabetes mellitus	0.000117	0.000755	CcSEcCtD
Bromocriptine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000117	0.000754	CcSEcCtD
Bromocriptine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000117	0.000754	CcSEcCtD
Bromocriptine—Infection—Metformin—type 2 diabetes mellitus	0.000117	0.00075	CcSEcCtD
Bromocriptine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000117	0.00075	CcSEcCtD
Bromocriptine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000116	0.000744	CcSEcCtD
Bromocriptine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000116	0.000743	CcSEcCtD
Bromocriptine—Shock—Metformin—type 2 diabetes mellitus	0.000115	0.000743	CcSEcCtD
Bromocriptine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000115	0.000741	CcSEcCtD
Bromocriptine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000115	0.00074	CcSEcCtD
Bromocriptine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000115	0.00074	CcSEcCtD
Bromocriptine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000115	0.000739	CcSEcCtD
Bromocriptine—Vertigo—Losartan—type 2 diabetes mellitus	0.000115	0.000738	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000115	0.000738	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000115	0.000738	CcSEcCtD
Bromocriptine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000115	0.000737	CcSEcCtD
Bromocriptine—Syncope—Losartan—type 2 diabetes mellitus	0.000114	0.000737	CcSEcCtD
Bromocriptine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000114	0.000735	CcSEcCtD
Bromocriptine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000114	0.000733	CcSEcCtD
Bromocriptine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000113	0.00073	CcSEcCtD
Bromocriptine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000113	0.000729	CcSEcCtD
Bromocriptine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000113	0.000727	CcSEcCtD
Bromocriptine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000112	0.000724	CcSEcCtD
Bromocriptine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000112	0.000723	CcSEcCtD
Bromocriptine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000112	0.000722	CcSEcCtD
Bromocriptine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000112	0.000721	CcSEcCtD
Bromocriptine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000112	0.000721	CcSEcCtD
Bromocriptine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000112	0.000721	CcSEcCtD
Bromocriptine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000112	0.000721	CcSEcCtD
Bromocriptine—Anorexia—Metformin—type 2 diabetes mellitus	0.000112	0.000719	CcSEcCtD
Bromocriptine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000111	0.000717	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000111	0.000716	CcSEcCtD
Bromocriptine—Alopecia—Ramipril—type 2 diabetes mellitus	0.000111	0.000715	CcSEcCtD
Bromocriptine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000111	0.000715	CcSEcCtD
Bromocriptine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000111	0.000713	CcSEcCtD
Bromocriptine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000111	0.000713	CcSEcCtD
Bromocriptine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000111	0.000712	CcSEcCtD
Bromocriptine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000111	0.000712	CcSEcCtD
Bromocriptine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.00011	0.000709	CcSEcCtD
Bromocriptine—Constipation—Valsartan—type 2 diabetes mellitus	0.00011	0.000709	CcSEcCtD
Bromocriptine—Infection—Irbesartan—type 2 diabetes mellitus	0.00011	0.000708	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00011	0.000707	CcSEcCtD
Bromocriptine—Fatigue—Orlistat—type 2 diabetes mellitus	0.00011	0.000706	CcSEcCtD
Bromocriptine—Hypotension—Metformin—type 2 diabetes mellitus	0.00011	0.000705	CcSEcCtD
Bromocriptine—Shock—Irbesartan—type 2 diabetes mellitus	0.000109	0.000701	CcSEcCtD
Bromocriptine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000109	0.000699	CcSEcCtD
Bromocriptine—Anxiety—Losartan—type 2 diabetes mellitus	0.000108	0.000697	CcSEcCtD
Bromocriptine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000108	0.000695	CcSEcCtD
Bromocriptine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000108	0.000692	CcSEcCtD
Bromocriptine—Tension—Ramipril—type 2 diabetes mellitus	0.000107	0.000691	CcSEcCtD
Bromocriptine—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000107	0.00069	CcSEcCtD
Bromocriptine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000107	0.000687	CcSEcCtD
Bromocriptine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000106	0.000684	CcSEcCtD
Bromocriptine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000106	0.000684	CcSEcCtD
Bromocriptine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000106	0.000679	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000105	0.000678	CcSEcCtD
Bromocriptine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000105	0.000678	CcSEcCtD
Bromocriptine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000105	0.000677	CcSEcCtD
Bromocriptine—Confusional state—Losartan—type 2 diabetes mellitus	0.000105	0.000676	CcSEcCtD
Bromocriptine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000105	0.000675	CcSEcCtD
Bromocriptine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000105	0.000673	CcSEcCtD
Bromocriptine—Somnolence—Metformin—type 2 diabetes mellitus	0.000104	0.000671	CcSEcCtD
Bromocriptine—Oedema—Losartan—type 2 diabetes mellitus	0.000104	0.00067	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000104	0.00067	CcSEcCtD
Bromocriptine—Infection—Losartan—type 2 diabetes mellitus	0.000103	0.000666	CcSEcCtD
Bromocriptine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000103	0.000666	CcSEcCtD
Bromocriptine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000103	0.000664	CcSEcCtD
Bromocriptine—Shock—Losartan—type 2 diabetes mellitus	0.000102	0.000659	CcSEcCtD
Bromocriptine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000102	0.000658	CcSEcCtD
Bromocriptine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000102	0.000657	CcSEcCtD
Bromocriptine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000102	0.000656	CcSEcCtD
Bromocriptine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000102	0.000655	CcSEcCtD
Bromocriptine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000102	0.000654	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000101	0.000652	CcSEcCtD
Bromocriptine—Fatigue—Metformin—type 2 diabetes mellitus	0.000101	0.000651	CcSEcCtD
Bromocriptine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000101	0.000651	CcSEcCtD
Bromocriptine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000101	0.000647	CcSEcCtD
Bromocriptine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000101	0.000647	CcSEcCtD
Bromocriptine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000101	0.000647	CcSEcCtD
Bromocriptine—Agitation—Ramipril—type 2 diabetes mellitus	0.000101	0.000647	CcSEcCtD
Bromocriptine—Constipation—Metformin—type 2 diabetes mellitus	0.0001	0.000645	CcSEcCtD
Bromocriptine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	9.94e-05	0.00064	CcSEcCtD
Bromocriptine—Anorexia—Losartan—type 2 diabetes mellitus	9.93e-05	0.000639	CcSEcCtD
Bromocriptine—Vomiting—Glyburide—type 2 diabetes mellitus	9.93e-05	0.000639	CcSEcCtD
Bromocriptine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	9.87e-05	0.000635	CcSEcCtD
Bromocriptine—Rash—Glyburide—type 2 diabetes mellitus	9.84e-05	0.000633	CcSEcCtD
Bromocriptine—Somnolence—Irbesartan—type 2 diabetes mellitus	9.84e-05	0.000633	CcSEcCtD
Bromocriptine—Dermatitis—Glyburide—type 2 diabetes mellitus	9.84e-05	0.000633	CcSEcCtD
Bromocriptine—Vertigo—Ramipril—type 2 diabetes mellitus	9.83e-05	0.000633	CcSEcCtD
Bromocriptine—Syncope—Ramipril—type 2 diabetes mellitus	9.82e-05	0.000632	CcSEcCtD
Bromocriptine—Headache—Glyburide—type 2 diabetes mellitus	9.78e-05	0.000629	CcSEcCtD
Bromocriptine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	9.74e-05	0.000627	CcSEcCtD
Bromocriptine—Hypotension—Losartan—type 2 diabetes mellitus	9.73e-05	0.000626	CcSEcCtD
Bromocriptine—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.67e-05	0.000622	CcSEcCtD
Bromocriptine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	9.62e-05	0.000619	CcSEcCtD
Bromocriptine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	9.62e-05	0.000619	CcSEcCtD
Bromocriptine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.59e-05	0.000617	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.59e-05	0.000617	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.56e-05	0.000615	CcSEcCtD
Bromocriptine—Fatigue—Irbesartan—type 2 diabetes mellitus	9.54e-05	0.000614	CcSEcCtD
Bromocriptine—Convulsion—Ramipril—type 2 diabetes mellitus	9.48e-05	0.00061	CcSEcCtD
Bromocriptine—Constipation—Irbesartan—type 2 diabetes mellitus	9.47e-05	0.000609	CcSEcCtD
Bromocriptine—Insomnia—Losartan—type 2 diabetes mellitus	9.42e-05	0.000606	CcSEcCtD
Bromocriptine—Paraesthesia—Losartan—type 2 diabetes mellitus	9.35e-05	0.000602	CcSEcCtD
Bromocriptine—Urticaria—Metformin—type 2 diabetes mellitus	9.32e-05	0.0006	CcSEcCtD
Bromocriptine—Dyspnoea—Losartan—type 2 diabetes mellitus	9.29e-05	0.000598	CcSEcCtD
Bromocriptine—Anxiety—Ramipril—type 2 diabetes mellitus	9.29e-05	0.000598	CcSEcCtD
Bromocriptine—Nausea—Glyburide—type 2 diabetes mellitus	9.27e-05	0.000597	CcSEcCtD
Bromocriptine—Abdominal pain—Metformin—type 2 diabetes mellitus	9.27e-05	0.000597	CcSEcCtD
Bromocriptine—Dizziness—Gliclazide—type 2 diabetes mellitus	9.27e-05	0.000597	CcSEcCtD
Bromocriptine—Somnolence—Losartan—type 2 diabetes mellitus	9.26e-05	0.000596	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	9.25e-05	0.000595	CcSEcCtD
Bromocriptine—Asthenia—Valsartan—type 2 diabetes mellitus	9.24e-05	0.000595	CcSEcCtD
Bromocriptine—ABCB1—liver—type 2 diabetes mellitus	9.19e-05	0.0025	CbGeAlD
Bromocriptine—Dyspepsia—Losartan—type 2 diabetes mellitus	9.17e-05	0.00059	CcSEcCtD
Bromocriptine—Asthenia—Orlistat—type 2 diabetes mellitus	9.13e-05	0.000588	CcSEcCtD
Bromocriptine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	9.12e-05	0.000587	CcSEcCtD
Bromocriptine—Dry mouth—Ramipril—type 2 diabetes mellitus	9.11e-05	0.000586	CcSEcCtD
Bromocriptine—Decreased appetite—Losartan—type 2 diabetes mellitus	9.06e-05	0.000583	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.05e-05	0.000582	CcSEcCtD
Bromocriptine—Confusional state—Ramipril—type 2 diabetes mellitus	9.01e-05	0.00058	CcSEcCtD
Bromocriptine—Fatigue—Losartan—type 2 diabetes mellitus	8.98e-05	0.000578	CcSEcCtD
Bromocriptine—Oedema—Ramipril—type 2 diabetes mellitus	8.93e-05	0.000575	CcSEcCtD
Bromocriptine—Vomiting—Gliclazide—type 2 diabetes mellitus	8.91e-05	0.000574	CcSEcCtD
Bromocriptine—Constipation—Losartan—type 2 diabetes mellitus	8.91e-05	0.000573	CcSEcCtD
Bromocriptine—Rash—Gliclazide—type 2 diabetes mellitus	8.84e-05	0.000569	CcSEcCtD
Bromocriptine—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.83e-05	0.000568	CcSEcCtD
Bromocriptine—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.81e-05	0.000567	CcSEcCtD
Bromocriptine—Urticaria—Irbesartan—type 2 diabetes mellitus	8.79e-05	0.000566	CcSEcCtD
Bromocriptine—Shock—Ramipril—type 2 diabetes mellitus	8.79e-05	0.000565	CcSEcCtD
Bromocriptine—Headache—Gliclazide—type 2 diabetes mellitus	8.78e-05	0.000565	CcSEcCtD
Bromocriptine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	8.76e-05	0.000564	CcSEcCtD
Bromocriptine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.75e-05	0.000563	CcSEcCtD
Bromocriptine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.75e-05	0.000563	CcSEcCtD
Bromocriptine—Tachycardia—Ramipril—type 2 diabetes mellitus	8.72e-05	0.000561	CcSEcCtD
Bromocriptine—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.71e-05	0.00056	CcSEcCtD
Bromocriptine—Skin disorder—Ramipril—type 2 diabetes mellitus	8.68e-05	0.000558	CcSEcCtD
Bromocriptine—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.58e-05	0.000552	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.52e-05	0.000548	CcSEcCtD
Bromocriptine—Dizziness—Valsartan—type 2 diabetes mellitus	8.52e-05	0.000548	CcSEcCtD
Bromocriptine—Anorexia—Ramipril—type 2 diabetes mellitus	8.51e-05	0.000548	CcSEcCtD
Bromocriptine—Dizziness—Orlistat—type 2 diabetes mellitus	8.42e-05	0.000542	CcSEcCtD
Bromocriptine—Asthenia—Metformin—type 2 diabetes mellitus	8.42e-05	0.000542	CcSEcCtD
Bromocriptine—Hypotension—Ramipril—type 2 diabetes mellitus	8.35e-05	0.000537	CcSEcCtD
Bromocriptine—Nausea—Gliclazide—type 2 diabetes mellitus	8.33e-05	0.000536	CcSEcCtD
Bromocriptine—Urticaria—Losartan—type 2 diabetes mellitus	8.28e-05	0.000533	CcSEcCtD
Bromocriptine—Body temperature increased—Losartan—type 2 diabetes mellitus	8.24e-05	0.00053	CcSEcCtD
Bromocriptine—Abdominal pain—Losartan—type 2 diabetes mellitus	8.24e-05	0.00053	CcSEcCtD
Bromocriptine—Vomiting—Valsartan—type 2 diabetes mellitus	8.19e-05	0.000527	CcSEcCtD
Bromocriptine—Rash—Valsartan—type 2 diabetes mellitus	8.12e-05	0.000523	CcSEcCtD
Bromocriptine—Dermatitis—Valsartan—type 2 diabetes mellitus	8.11e-05	0.000522	CcSEcCtD
Bromocriptine—Vomiting—Orlistat—type 2 diabetes mellitus	8.09e-05	0.000521	CcSEcCtD
Bromocriptine—Insomnia—Ramipril—type 2 diabetes mellitus	8.08e-05	0.00052	CcSEcCtD
Bromocriptine—Headache—Valsartan—type 2 diabetes mellitus	8.07e-05	0.000519	CcSEcCtD
Bromocriptine—Diarrhoea—Metformin—type 2 diabetes mellitus	8.03e-05	0.000516	CcSEcCtD
Bromocriptine—Rash—Orlistat—type 2 diabetes mellitus	8.03e-05	0.000516	CcSEcCtD
Bromocriptine—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.02e-05	0.000516	CcSEcCtD
Bromocriptine—Dermatitis—Orlistat—type 2 diabetes mellitus	8.02e-05	0.000516	CcSEcCtD
Bromocriptine—Headache—Orlistat—type 2 diabetes mellitus	7.97e-05	0.000513	CcSEcCtD
Bromocriptine—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.96e-05	0.000512	CcSEcCtD
Bromocriptine—Asthenia—Irbesartan—type 2 diabetes mellitus	7.94e-05	0.000511	CcSEcCtD
Bromocriptine—Somnolence—Ramipril—type 2 diabetes mellitus	7.94e-05	0.000511	CcSEcCtD
Bromocriptine—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.86e-05	0.000506	CcSEcCtD
Bromocriptine—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.77e-05	0.0005	CcSEcCtD
Bromocriptine—Dizziness—Metformin—type 2 diabetes mellitus	7.76e-05	0.000499	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.71e-05	0.000496	CcSEcCtD
Bromocriptine—Fatigue—Ramipril—type 2 diabetes mellitus	7.7e-05	0.000496	CcSEcCtD
Bromocriptine—Nausea—Valsartan—type 2 diabetes mellitus	7.65e-05	0.000492	CcSEcCtD
Bromocriptine—Constipation—Ramipril—type 2 diabetes mellitus	7.64e-05	0.000492	CcSEcCtD
Bromocriptine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.000487	CcSEcCtD
Bromocriptine—Nausea—Orlistat—type 2 diabetes mellitus	7.56e-05	0.000486	CcSEcCtD
Bromocriptine—Asthenia—Losartan—type 2 diabetes mellitus	7.47e-05	0.000481	CcSEcCtD
Bromocriptine—Vomiting—Metformin—type 2 diabetes mellitus	7.46e-05	0.00048	CcSEcCtD
Bromocriptine—Rash—Metformin—type 2 diabetes mellitus	7.4e-05	0.000476	CcSEcCtD
Bromocriptine—Dermatitis—Metformin—type 2 diabetes mellitus	7.39e-05	0.000475	CcSEcCtD
Bromocriptine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.36e-05	0.000474	CcSEcCtD
Bromocriptine—Headache—Metformin—type 2 diabetes mellitus	7.35e-05	0.000473	CcSEcCtD
Bromocriptine—Dizziness—Irbesartan—type 2 diabetes mellitus	7.32e-05	0.000471	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.3e-05	0.00047	CcSEcCtD
Bromocriptine—Diarrhoea—Losartan—type 2 diabetes mellitus	7.13e-05	0.000459	CcSEcCtD
Bromocriptine—Urticaria—Ramipril—type 2 diabetes mellitus	7.1e-05	0.000457	CcSEcCtD
Bromocriptine—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000454	CcSEcCtD
Bromocriptine—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000454	CcSEcCtD
Bromocriptine—Vomiting—Irbesartan—type 2 diabetes mellitus	7.04e-05	0.000453	CcSEcCtD
Bromocriptine—Rash—Irbesartan—type 2 diabetes mellitus	6.98e-05	0.000449	CcSEcCtD
Bromocriptine—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.97e-05	0.000449	CcSEcCtD
Bromocriptine—Nausea—Metformin—type 2 diabetes mellitus	6.97e-05	0.000448	CcSEcCtD
Bromocriptine—Headache—Irbesartan—type 2 diabetes mellitus	6.93e-05	0.000446	CcSEcCtD
Bromocriptine—Dizziness—Losartan—type 2 diabetes mellitus	6.89e-05	0.000443	CcSEcCtD
Bromocriptine—Vomiting—Losartan—type 2 diabetes mellitus	6.62e-05	0.000426	CcSEcCtD
Bromocriptine—Nausea—Irbesartan—type 2 diabetes mellitus	6.58e-05	0.000423	CcSEcCtD
Bromocriptine—Rash—Losartan—type 2 diabetes mellitus	6.57e-05	0.000423	CcSEcCtD
Bromocriptine—Dermatitis—Losartan—type 2 diabetes mellitus	6.56e-05	0.000422	CcSEcCtD
Bromocriptine—Headache—Losartan—type 2 diabetes mellitus	6.53e-05	0.00042	CcSEcCtD
Bromocriptine—Asthenia—Ramipril—type 2 diabetes mellitus	6.41e-05	0.000412	CcSEcCtD
Bromocriptine—Nausea—Losartan—type 2 diabetes mellitus	6.19e-05	0.000398	CcSEcCtD
Bromocriptine—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000393	CcSEcCtD
Bromocriptine—Dizziness—Ramipril—type 2 diabetes mellitus	5.91e-05	0.00038	CcSEcCtD
Bromocriptine—Vomiting—Ramipril—type 2 diabetes mellitus	5.68e-05	0.000365	CcSEcCtD
Bromocriptine—Rash—Ramipril—type 2 diabetes mellitus	5.63e-05	0.000362	CcSEcCtD
Bromocriptine—Dermatitis—Ramipril—type 2 diabetes mellitus	5.63e-05	0.000362	CcSEcCtD
Bromocriptine—Headache—Ramipril—type 2 diabetes mellitus	5.6e-05	0.00036	CcSEcCtD
Bromocriptine—Nausea—Ramipril—type 2 diabetes mellitus	5.31e-05	0.000341	CcSEcCtD
Bromocriptine—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.87e-06	1.48e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.86e-06	1.47e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.86e-06	1.47e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.86e-06	1.47e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.86e-06	1.47e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.86e-06	1.47e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.86e-06	1.47e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.85e-06	1.46e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.85e-06	1.46e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.85e-06	1.46e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.85e-06	1.46e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.85e-06	1.46e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.84e-06	1.46e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.84e-06	1.45e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.84e-06	1.45e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.83e-06	1.45e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.83e-06	1.45e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.83e-06	1.45e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.82e-06	1.44e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.82e-06	1.44e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.82e-06	1.44e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—IL6—type 2 diabetes mellitus	1.82e-06	1.44e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.81e-06	1.43e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.81e-06	1.43e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.81e-06	1.43e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.81e-06	1.43e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.81e-06	1.43e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.8e-06	1.43e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.8e-06	1.43e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.8e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.8e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.8e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.79e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.79e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.79e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.79e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.78e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.78e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.78e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.77e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.77e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.77e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—SRC—type 2 diabetes mellitus	1.77e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.77e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.77e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.76e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.76e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.76e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.76e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.75e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.75e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.75e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.75e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.74e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.73e-06	1.37e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.73e-06	1.37e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.73e-06	1.37e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.72e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.72e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.72e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.72e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.71e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.71e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.71e-06	1.35e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.7e-06	1.35e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.7e-06	1.34e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.7e-06	1.34e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.69e-06	1.34e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.69e-06	1.34e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.69e-06	1.34e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.69e-06	1.34e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.69e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.68e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.68e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.68e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.68e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.67e-06	1.32e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.67e-06	1.32e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.67e-06	1.32e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.66e-06	1.32e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.66e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.65e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.65e-06	1.3e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.64e-06	1.3e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.64e-06	1.3e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.64e-06	1.29e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.62e-06	1.28e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.62e-06	1.28e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.61e-06	1.28e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.61e-06	1.28e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.61e-06	1.27e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.6e-06	1.27e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.6e-06	1.27e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.6e-06	1.26e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.59e-06	1.26e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.58e-06	1.25e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.58e-06	1.25e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.57e-06	1.25e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.57e-06	1.25e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.57e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.57e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.57e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.57e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.55e-06	1.23e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.55e-06	1.23e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.55e-06	1.23e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.55e-06	1.23e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.55e-06	1.23e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.54e-06	1.22e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.54e-06	1.22e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.54e-06	1.22e-05	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.54e-06	1.22e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.54e-06	1.22e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.54e-06	1.22e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.53e-06	1.21e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.53e-06	1.21e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.52e-06	1.2e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.52e-06	1.2e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.51e-06	1.19e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.5e-06	1.19e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.5e-06	1.18e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.49e-06	1.18e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.49e-06	1.18e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.49e-06	1.18e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.47e-06	1.17e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.47e-06	1.16e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.47e-06	1.16e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.46e-06	1.15e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.46e-06	1.15e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.45e-06	1.15e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.45e-06	1.15e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.45e-06	1.15e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.45e-06	1.15e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.44e-06	1.14e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.44e-06	1.14e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.44e-06	1.14e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.43e-06	1.13e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.43e-06	1.13e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.43e-06	1.13e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.43e-06	1.13e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.43e-06	1.13e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.42e-06	1.13e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.42e-06	1.12e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.41e-06	1.12e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.41e-06	1.12e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.4e-06	1.11e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	1.4e-06	1.11e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	1.4e-06	1.11e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.4e-06	1.11e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.4e-06	1.11e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.4e-06	1.11e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	1.39e-06	1.1e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.39e-06	1.1e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.39e-06	1.1e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.38e-06	1.09e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.38e-06	1.09e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.37e-06	1.08e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.37e-06	1.08e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.36e-06	1.08e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.35e-06	1.07e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.35e-06	1.07e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.35e-06	1.07e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.35e-06	1.07e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.35e-06	1.07e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.34e-06	1.06e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL6—type 2 diabetes mellitus	1.34e-06	1.06e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.33e-06	1.05e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.33e-06	1.05e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.33e-06	1.05e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.32e-06	1.04e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.31e-06	1.04e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.31e-06	1.04e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.31e-06	1.03e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.3e-06	1.03e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.3e-06	1.03e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.3e-06	1.03e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.3e-06	1.03e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.3e-06	1.03e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.29e-06	1.02e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.29e-06	1.02e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.29e-06	1.02e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.28e-06	1.02e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.28e-06	1.01e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.27e-06	1.01e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.27e-06	1e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.26e-06	9.99e-06	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.26e-06	9.95e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.26e-06	9.94e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.25e-06	9.86e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.24e-06	9.8e-06	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.24e-06	9.79e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.23e-06	9.75e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.21e-06	9.58e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.21e-06	9.57e-06	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.21e-06	9.55e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.2e-06	9.46e-06	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	1.19e-06	9.42e-06	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.19e-06	9.42e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.19e-06	9.42e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.19e-06	9.38e-06	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.18e-06	9.34e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.18e-06	9.33e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.17e-06	9.28e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.17e-06	9.23e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.17e-06	9.22e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.14e-06	9.04e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.14e-06	8.99e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.13e-06	8.94e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.12e-06	8.84e-06	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.11e-06	8.81e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.11e-06	8.81e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	1.11e-06	8.77e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.1e-06	8.71e-06	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.1e-06	8.69e-06	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.1e-06	8.69e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.09e-06	8.59e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.08e-06	8.57e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.08e-06	8.55e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.08e-06	8.55e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.08e-06	8.51e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.06e-06	8.4e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.04e-06	8.21e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	1.03e-06	8.17e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	1e-06	7.95e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1e-06	7.92e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.92e-07	7.85e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	9.89e-07	7.82e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	9.88e-07	7.82e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	9.7e-07	7.67e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.58e-07	7.58e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.53e-07	7.54e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	9.51e-07	7.53e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.27e-07	7.33e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.12e-07	7.22e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	9.11e-07	7.21e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	9e-07	7.12e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	8.97e-07	7.09e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	8.78e-07	6.95e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	8.72e-07	6.9e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.41e-07	6.65e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	8.34e-07	6.6e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	8.34e-07	6.6e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.27e-07	6.55e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	8.16e-07	6.45e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.1e-07	6.41e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	7.63e-07	6.04e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.53e-07	5.95e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	6.22e-07	4.92e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	4.97e-07	3.93e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.83e-07	3.03e-06	CbGpPWpGaD
